NewGenIvf Group Limited
NIVF
$1.80
$0.052.86%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.43M | 5.68M | 5.68M | 5.41M | 5.14M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.43M | 5.68M | 5.68M | 5.41M | 5.14M |
| Cost of Revenue | 3.61M | 4.19M | 4.30M | 3.88M | 3.45M |
| Gross Profit | 1.83M | 1.48M | 1.39M | 1.53M | 1.68M |
| SG&A Expenses | 2.99M | 1.32M | 1.34M | 1.49M | 1.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.59M | 5.52M | 5.64M | 5.37M | 5.09M |
| Operating Income | -1.16M | 161.50K | 48.20K | 45.30K | 42.40K |
| Income Before Tax | -960.80K | -122.50K | 15.70K | 62.10K | 108.50K |
| Income Tax Expenses | -486.70K | -83.70K | -83.70K | -41.80K | 100.00 |
| Earnings from Continuing Operations | -0.47 | -0.04 | 0.10 | 0.10 | 0.11 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -50.60K | -42.00K | -57.90K | -18.10K | 21.70K |
| Net Income | -524.70K | -80.90K | 41.50K | 85.90K | 130.30K |
| EBIT | -1.16M | 161.50K | 48.20K | 45.30K | 42.40K |
| EBITDA | -1.14M | 206.10K | 88.00K | 88.50K | 89.00K |
| EPS Basic | -44.76 | -26.31 | -24.35 | -4.81 | 14.72 |
| Normalized Basic EPS | -39.07 | -19.39 | -18.56 | -6.19 | 6.19 |
| EPS Diluted | -44.76 | -26.34 | -24.38 | -4.85 | 14.69 |
| Normalized Diluted EPS | -39.07 | -19.39 | -18.56 | -6.19 | 6.19 |
| Average Basic Shares Outstanding | 59.30K | 53.10K | 43.00K | 32.90K | 22.80K |
| Average Diluted Shares Outstanding | 59.30K | 53.10K | 43.00K | 32.90K | 22.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |